Exact Mass: 228.1474

Exact Mass Matches: 228.1474

Found 60 metabolites which its exact mass value is equals to given mass value 228.1474, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Leucylproline

(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C11H20N2O3 (228.1474)


Leucylproline is a dipeptide composed of leucine and proline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. It is found in urine (PMID: 3782411). A dipeptide found in urine (PMID: 3782411). This is a proteolytic breakdown product of larger proteins. [HMDB]

   

Isoleucylproline

(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C11H20N2O3 (228.1474)


Isoleucylproline is a dipeptide composed of isoleucine and proline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. It is found in urine (PMID: 3782411).

   

N,N,N-Trimethyl-L-alanyl-L-proline betaine

(2S)-1-[(2S)-2-(trimethylazaniumyl)propanoyl]pyrrolidine-2-carboxylate

C11H20N2O3 (228.1474)


N,N,N-Trimethyl-L-alanyl-L-proline betaine (TMAP) belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. TMAP was previously an unknown potential plasma biomarker for glomerular filtration rate (GFR) but its structure has since been elucidated (PMID: 28706470). TMAP has also been identified as a potential plasma biomarker of reduced kidney function in early chronic kidney disease (CKD), end stage renal disease (ESRD), and hemodialytic clearance (PMID: 31048706).

   

Pro-leu

2-{[hydroxy(pyrrolidin-2-yl)methylidene]amino}-4-methylpentanoic acid

C11H20N2O3 (228.1474)


   

Pro-Ile

(2S,3S)-2-({hydroxy[(2S)-pyrrolidin-2-yl]methylidene}amino)-3-methylpentanoic acid

C11H20N2O3 (228.1474)


   

MCULE-3665705986

MCULE-3665705986

C11H20N2O3 (228.1474)


   

MCULE-2919364138

MCULE-2919364138

C11H20N2O3 (228.1474)


   

L-Prolyl-L-leucin-anhydrid|Prolyl-leucyl-anhydrid

L-Prolyl-L-leucin-anhydrid|Prolyl-leucyl-anhydrid

C11H20N2O3 (228.1474)


   

tert-butyl 2-carbamoylpiperidine-1-carboxylate

tert-butyl 2-carbamoylpiperidine-1-carboxylate

C11H20N2O3 (228.1474)


   

alpha-Methyldethiobiotin

alpha-Methyldethiobiotin

C11H20N2O3 (228.1474)


   

(2S,3S)-3-Methyl-2-((S)-pyrrolidine-2-carboxamido)pentanoic acid

(2S,3S)-3-Methyl-2-((S)-pyrrolidine-2-carboxamido)pentanoic acid

C11H20N2O3 (228.1474)


   

Pro-Leu

H-Pro-Leu-OH

C11H20N2O3 (228.1474)


A dipeptide formed from L-proline and L-leucine residues.

   

L-Prolyl-L-isoleucine

L-Prolyl-L-isoleucine

C11H20N2O3 (228.1474)


   

Leucylproline

Leucylproline

C11H20N2O3 (228.1474)


Annotation level-3

   
   
   
   
   

1-L-Leucyl-L-proline

1-L-Leucyl-L-proline

C11H20N2O3 (228.1474)


   

Ile-pro

L-Isoleucyl-L-proline

C11H20N2O3 (228.1474)


A dipeptide formed from L-isoleucine and L-proline residues.

   

N-Boc-D-2-Piperidinecarboxamide

N-Boc-D-2-Piperidinecarboxamide

C11H20N2O3 (228.1474)


   

tert-butyl 5-oxa-2,8-diazaspiro[3.5]nonane-8-carboxylate

tert-butyl 5-oxa-2,8-diazaspiro[3.5]nonane-8-carboxylate

C11H20N2O3 (228.1474)


   

(S)-1-BOC-3-PIPERIDINECARBOXAMIDE

(S)-1-BOC-3-PIPERIDINECARBOXAMIDE

C11H20N2O3 (228.1474)


   

tert-butyl 4-(2-oxoethyl)piperazine-1-carboxylate

tert-butyl 4-(2-oxoethyl)piperazine-1-carboxylate

C11H20N2O3 (228.1474)


   

(R)-1-BENZYL-BETA-PROLINOL

(R)-1-BENZYL-BETA-PROLINOL

C11H20N2O3 (228.1474)


   

ethyl 1-(dimethylcarbamoyl)piperidine-2-carboxylate

ethyl 1-(dimethylcarbamoyl)piperidine-2-carboxylate

C11H20N2O3 (228.1474)


   

2-Methyl-2-propanyl 9-oxa-3,7-diazabicyclo[3.3.1]nonane-3-carboxy latato

2-Methyl-2-propanyl 9-oxa-3,7-diazabicyclo[3.3.1]nonane-3-carboxy latato

C11H20N2O3 (228.1474)


   

1-ETHYL-4-(TERT-BUTYLOXYCARBONYL)PIPERAZIN-2-ONE

1-ETHYL-4-(TERT-BUTYLOXYCARBONYL)PIPERAZIN-2-ONE

C11H20N2O3 (228.1474)


   

(S)-1-Boc-N-Methylpyrrolidine-2-carboxamide

(S)-1-Boc-N-Methylpyrrolidine-2-carboxamide

C11H20N2O3 (228.1474)


   

(R)-tert-Butyl (2-oxoazepan-3-yl)carbamate

(R)-tert-Butyl (2-oxoazepan-3-yl)carbamate

C11H20N2O3 (228.1474)


   

1-Butyl-3-Methylimidazolium (L)-Lactate

1-Butyl-3-Methylimidazolium (L)-Lactate

C11H20N2O3 (228.1474)


   

7-Boc-3-oxa-7,9-diazabicyclo[3.3.1]nonane

7-Boc-3-oxa-7,9-diazabicyclo[3.3.1]nonane

C11H20N2O3 (228.1474)


   

(S)-tert-Butyl (2-oxoazepan-3-yl)carbamate

(S)-tert-Butyl (2-oxoazepan-3-yl)carbamate

C11H20N2O3 (228.1474)


   

tert-butyl (3S)-3-acetamidopyrrolidine-1-carboxylate

tert-butyl (3S)-3-acetamidopyrrolidine-1-carboxylate

C11H20N2O3 (228.1474)


   

(+/-)-N-Alpha-Boc-Amino-Epsilon-Caprolactam

(+/-)-N-Alpha-Boc-Amino-Epsilon-Caprolactam

C11H20N2O3 (228.1474)


   

ethyl 1-(dimethylcarbamoyl)piperidine-4-carboxylate

ethyl 1-(dimethylcarbamoyl)piperidine-4-carboxylate

C11H20N2O3 (228.1474)


   

N-Boc-DL-2-piperidinecarboxamide

N-Boc-DL-2-piperidinecarboxamide

C11H20N2O3 (228.1474)


   

tert-butyl 5-oxa-2,8-diazaspiro[3.5]nonane-2-carboxylate

tert-butyl 5-oxa-2,8-diazaspiro[3.5]nonane-2-carboxylate

C11H20N2O3 (228.1474)


   

tert-Butyl 4-carbamoylpiperidine-1-carboxylate

tert-Butyl 4-carbamoylpiperidine-1-carboxylate

C11H20N2O3 (228.1474)


   

(s)-1-n-boc-piperidine-2-carboxamide

(s)-1-n-boc-piperidine-2-carboxamide

C11H20N2O3 (228.1474)


   

1-Boc-3-Carbamoylpiperidine

1-Boc-3-Carbamoylpiperidine

C11H20N2O3 (228.1474)


   

4-{[(Cyclohexylamino)carbonyl]amino}butanoic acid

4-{[(Cyclohexylamino)carbonyl]amino}butanoic acid

C11H20N2O3 (228.1474)


   

Prolylisoleucine

Prolylisoleucine

C11H20N2O3 (228.1474)


   

1-(2-Amino-4-methylpentanoyl)pyrrolidine-2-carboxylic acid

1-(2-Amino-4-methylpentanoyl)pyrrolidine-2-carboxylic acid

C11H20N2O3 (228.1474)


   

N-L-Prolyl-L-isoleucine

N-L-Prolyl-L-isoleucine

C11H20N2O3 (228.1474)


   

(2S)-1-[(2S)-2-azaniumyl-4-methylpentanoyl]pyrrolidine-2-carboxylate

(2S)-1-[(2S)-2-azaniumyl-4-methylpentanoyl]pyrrolidine-2-carboxylate

C11H20N2O3 (228.1474)


   
   

(2S)-4-methyl-2-[[(2S)-pyrrolidin-1-ium-2-carbonyl]amino]pentanoate

(2S)-4-methyl-2-[[(2S)-pyrrolidin-1-ium-2-carbonyl]amino]pentanoate

C11H20N2O3 (228.1474)


   

1-(2-Amino-3-methylpentanoyl)pyrrolidine-2-carboxylic acid

1-(2-Amino-3-methylpentanoyl)pyrrolidine-2-carboxylic acid

C11H20N2O3 (228.1474)


   

Leu-Pro zwitterion

Leu-Pro zwitterion

C11H20N2O3 (228.1474)


A peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Leu-Pro.

   

Pro-Ile

Pro-Ile

C11H20N2O3 (228.1474)


A dipeptide formed from L-proline and L-isoleucine residues.

   

Isoleucyl-proline

Isoleucyl-proline

C11H20N2O3 (228.1474)


   

Leu-pro

Leu-pro

C11H20N2O3 (228.1474)


A dipeptide formed from L-leucine and L-proline residues.

   

N,N,N-Trimethyl-alanylproline betaine

N,N,N-Trimethyl-alanylproline betaine

C11H20N2O3 (228.1474)


   

n-[2-(hydroxyimino)-4-methylpentanoyl]-3-methylbutanimidic acid

n-[2-(hydroxyimino)-4-methylpentanoyl]-3-methylbutanimidic acid

C11H20N2O3 (228.1474)


   

2-amino-4-methylpentanoyl pyrrolidine-2-carboxylate

2-amino-4-methylpentanoyl pyrrolidine-2-carboxylate

C11H20N2O3 (228.1474)


   

n-[(2z)-2-(hydroxyimino)-4-methylpentanoyl]-3-methylbutanimidic acid

n-[(2z)-2-(hydroxyimino)-4-methylpentanoyl]-3-methylbutanimidic acid

C11H20N2O3 (228.1474)


   

(2s)-2-amino-4-methylpentanoyl (2s)-pyrrolidine-2-carboxylate

(2s)-2-amino-4-methylpentanoyl (2s)-pyrrolidine-2-carboxylate

C11H20N2O3 (228.1474)


   

6-(2-hydroxy-5-methyl-4,5-dihydro-3h-imidazol-4-yl)-2-methylhexanoic acid

6-(2-hydroxy-5-methyl-4,5-dihydro-3h-imidazol-4-yl)-2-methylhexanoic acid

C11H20N2O3 (228.1474)


   

(3s,6s)-3-[(2s)-butan-2-yl]-6-(3-hydroxypropyl)-3,6-dihydropyrazine-2,5-diol

(3s,6s)-3-[(2s)-butan-2-yl]-6-(3-hydroxypropyl)-3,6-dihydropyrazine-2,5-diol

C11H20N2O3 (228.1474)